Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Persistence, compliance, discontinuation rates and switch rates in denosumab and bisphosphonate treatment of bone metastases in cancer patients: reasons of switch, osteonecrosis of the jaw (ONJ) and other critical points.
Rossi M, Gambino A, Cabras M, Alessio M, Fusco V. Rossi M, et al. Among authors: fusco v. Support Care Cancer. 2021 Aug;29(8):4185-4186. doi: 10.1007/s00520-021-06100-4. Epub 2021 Feb 25. Support Care Cancer. 2021. PMID: 33634351 No abstract available.
Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients.
Santini D, Vincenzi B, Adamo V, Addeo R, Fusco V, Russo A, Montemurro F, Roato I, Redana S, Lanzetta G, Satolli MA, Berruti A, Leoni V, Galluzzo S, Antimi M, Ferraro G, Rossi M, Del Prete S, Valerio MR, Marra M, Caraglia M, Tonini G. Santini D, et al. Among authors: fusco v. Oncol Rep. 2011 Jun;25(6):1545-8. doi: 10.3892/or.2011.1235. Epub 2011 Mar 28. Oncol Rep. 2011. PMID: 21455582 Free article.
Up to a quarter of patients with osteonecrosis of the jaw associated with antiresorptive agents remain undiagnosed.
Fedele S, Bedogni G, Scoletta M, Favia G, Colella G, Agrillo A, Bettini G, Di Fede O, Oteri G, Fusco V, Gabriele M, Ottolenghi L, Valsecchi S, Porter S, Fung PP, Saia G, Campisi G, Bedogni A. Fedele S, et al. Among authors: fusco v. Br J Oral Maxillofac Surg. 2015 Jan;53(1):13-7. doi: 10.1016/j.bjoms.2014.09.001. Epub 2014 Oct 2. Br J Oral Maxillofac Surg. 2015. PMID: 25282593 Free article.
RE: Regorafenib Also Can Cause Osteonecrosis of the Jaw.
Fusco V, Campisi G, Numico G, Migliorati CA, Santini D, Bedogni A. Fusco V, et al. J Natl Cancer Inst. 2016 Jul 7;108(9):djw155. doi: 10.1093/jnci/djw155. Print 2016 Sep. J Natl Cancer Inst. 2016. PMID: 27390045 No abstract available.
Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study.
Fung P, Bedogni G, Bedogni A, Petrie A, Porter S, Campisi G, Bagan J, Fusco V, Saia G, Acham S, Musto P, Petrucci MT, Diz P, Colella G, Mignogna MD, Pentenero M, Arduino P, Lodi G, Maiorana C, Manfredi M, Hallberg P, Wadelius M, Takaoka K, Leung YY, Bonacina R, Schiødt M, Lakatos P, Taylor T, De Riu G, Favini G, Rogers SN, Pirmohamed M, Nicoletti P; GENVABO Consortium; Fedele S. Fung P, et al. Among authors: fusco v. Oral Dis. 2017 May;23(4):477-483. doi: 10.1111/odi.12632. Epub 2017 Mar 6. Oral Dis. 2017. PMID: 28039941 Free article.
222 results